Influence of Clinical, Angiographic, and Developmental Characteristics and COVID-19 Severity and Vaccination Status

Yethindra Vityala1, Mahesh Palagudi2, Sneha Para3

  • 1Honorary International Faculty, AJ Institute of Medical Sciences and Research Centre, Mangalore, Karnataka, India.

Journal of Mid-Life Health
|November 29, 2024
PubMed

Insights

Younger patients experiencing acute myocardial infarction (AMI) often have higher cholesterol and triglyceride levels and are more likely to be smokers. Unvaccinated individuals with AMI had more severe COVID-19 outcomes.

Area of Science:

  • Cardiology
  • Genetics
  • Infectious Diseases

Background:

  • Atherosclerosis is a primary cause of ischemic cardiovascular disease (CVD).
  • Genetic factors contribute to 20%-40% of acute myocardial infarction (AMI) cases in individuals under 50.
  • Coronavirus disease 2019 (COVID-19) increases the risk of blood clots and AMI.

Purpose of the Study:

  • To characterize clinical, angiographic, and developmental factors in patients aged ≤45 with AMI.
  • To assess COVID-19 severity and vaccination status in younger AMI patients.

Main Methods:

  • Retrospective analysis of 2624 patients with AMI.
  • Review of coronary angiography, percutaneous coronary intervention results, and medical reports.
  • Inclusion criteria: age >18 years, universal AMI definition; exclusion criteria: missing data.

Main Results:

  • Higher total cholesterol and triglyceride levels were observed in patients aged ≤45 years compared to older patients.
  • Unvaccinated patients, across both age groups, experienced more severe and critical COVID-19 infections.
  • Younger AMI patients were more frequently smokers and had fewer comorbidities like hypertension or diabetes.

Conclusions:

  • Younger AMI patients exhibit distinct risk factor profiles, including hypercholesterolemia, hypertriglyceridemia, and a higher prevalence of smoking.
  • These patients were more likely to present with single-vessel disease, Type C lesions, and a history of drug-eluting stent use.
  • COVID-19 severity was linked to vaccination status, with unvaccinated individuals facing worse outcomes.
Abstract

Related Concept Videos

Myocarditis III: Medical Management01:14

Myocarditis III: Medical Management

Myocarditis: Comprehensive Medical ManagementMyocarditis, the heart muscle inflammation, requires a comprehensive medical management strategy that addresses the underlying cause, provides supportive care, manages symptoms, and reduces cardiac workload.Infections and Autoimmune CausesAdminister appropriate antimicrobial therapy when an infectious agent causes myocarditis. For instance, penicillin treats infections caused by Group A Streptococcus. In cases where autoimmune processes are...
2
Myocarditis II: Clinical features and Diagnostic Tests01:27

Myocarditis II: Clinical features and Diagnostic Tests

Myocarditis is an inflammation of the heart muscle. The symptoms vary widely, encompassing asymptomatic presentations to severe, acute manifestations.Clinical PresentationAsymptomatic cases: In some instances, myocarditis may be asymptomatic, with the infection resolving without intervention. These cases often go undetected unless discovered incidentally through diagnostic imaging or tests conducted for other reasons.General Early Symptoms: Early symptoms of myocarditis are non-specific and can...
2
Rheumatic Heart Disease II: Clinical Manifestations and Diagnostic Studies01:22

Rheumatic Heart Disease II: Clinical Manifestations and Diagnostic Studies

The key clinical manifestations of Rheumatic heart disease (RHD) include several distinct cardiac symptoms.Carditis, a hallmark of acute rheumatic fever, involves inflammation of the heart's endocardium, myocardium, and pericardium. Chronic RHD often results from recurrent episodes of carditis. Its symptoms include the following:Murmurs are caused by valvular damage, especially to the mitral and aortic valves. Mitral stenosis or regurgitation is common, with characteristic heart murmurs...
7
Endocarditis II: Clinical features and Diagnostic Tests01:25

Endocarditis II: Clinical features and Diagnostic Tests

Endocarditis can present various clinical features depending on the causative organism and the patient's underlying health conditions. Initially, the clinical features of infective endocarditis develop gradually, presenting with nonspecific symptoms that can be easily mistaken for other illnesses.General SymptomsEarly symptoms of infective endocarditis are fever, chills, weakness, malaise, fatigue, and weight loss. These symptoms reflect the systemic nature of the infection and the body's...
2
Ischemic Heart Disease: Overview01:17

Ischemic Heart Disease: Overview

Ischemic heart disease occurs when the heart's blood supply dwindles, causing an ominous lack of oxygen and nutrients. This deficiency, stemming from reduced or obstructed blood flow, spells danger, leading to heart muscle damage and dysfunction.
Atherosclerosis, the primary malefactor, orchestrates this dangerous condition. It manifests as the accumulation of fatty deposits, akin to insidious plaques, within arterial walls. As time elapses, these plaques metamorphose, hardening and...
1.2K
Myocarditis I: Introduction01:21

Myocarditis I: Introduction

Myocarditis is inflammation of the myocardium, which is the muscular layer of the heart.EtiologyMyocarditis has a diverse etiology, including a wide range of infectious and non-infectious causes:Infectious CausesViral: Common viruses include Coxsackie A and B, adenovirus, parvovirus B19, enteroviruses, and influenza A.Bacterial: Examples include infections caused by Streptococcus, Staphylococcus, and Mycoplasma species.Rickettsial: Infections like Rocky Mountain spotted fever can result in...
2